The Study
Nfil3 integrates circadian rhythm and microbial metabolite signaling to maintain gut–liver immune–metabolic homeostasis under high-fat diet stress
This study looked at mice and a few people to see how gut bacteria and a gene called Nfil3 might be connected to weight gain and liver problems. It found patterns—like when bacteria change, the gene acts differently—but it didn’t prove that one thing causes the other, especially in people.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
When mice eat too much fat, their gut bacteria get out of balance, making them gain weight and get fatty liver. A protein called Nfil3 in their bodies gets too active and makes things worse. But if you remove Nfil3 or give them a special probiotic (VSL#3), they stay healthier.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 561 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this suggests that fixing gut bacteria or targeting Nfil3 could help prevent obesity and fatty liver in humans, but it hasn't been tested in people yet.
- 2Mice on high-fat diet gained weight and had fatty livers; removing Nfil3 or giving VSL#3 cut weight gain by ~30-50% and improved glucose tolerance and liver health.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Journal of Translational Medicine
Year
2026
Authors
Yung-Ni Lin, Wei-Hao Peng, Yu-Chin Huang, C. Lai, Jia-Rou Hsu, Jzy-Yu Wang, Yi-Chu Kao, Li-Ling Wu
Related Content
Claims (6)
In mice on a high-fat diet, removing the Nfil3 gene results in less weight gain, less fat accumulation in the liver, lower blood sugar levels, and reduced leakage in the intestine.
In mice eating a high-fat diet, taking the probiotic VSL#3 leads to less weight gain, better blood sugar control, lower liver enzyme levels, and reduced intestinal leakage, and these changes require part of the Nfil3 signaling pathway.
In mice, a high-fat diet changes the gut bacteria by decreasing types that produce short-chain fatty acids and increasing types that produce endotoxins, which results in a leakier intestine and liver inflammation.
In people with obesity, immune cells in the blood show higher levels of Nfil3 protein and lower levels of circadian rhythm genes, alongside increased activity in inflammatory pathways and decreased levels of receptors that bind short-chain fatty acids.
In mice fed a high-fat diet, the probiotic VSL#3 changes gut bacteria activity to increase functions related to amino acid processing and redox balance while decreasing functions related to lipopolysaccharide production.
Gut microbes follow a daily rhythm, and prolonged periods without food are necessary for them to carry out repair processes in the lining of the intestine.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.